March 04, 2026

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

Conexiant

February 19, 2026

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

Conexiant

February 13, 2026

Conjugative CRISPR System Cuts Resistance

Mobile gene drive-like platform spreads between bacteria and reduces ampicillin resistance by up to 5 logs while enabling cassette reversal

Conexiant

February 12, 2026

15x Spike: What Louisville Found

Scientists trace a PFAS surge 400 miles upstream.

KFF Health News

February 09, 2026

When Constipation Signals Something More

Coordinated clinical and public health response supports timely identification and recovery of infant botulism.

Conexiant

February 06, 2026

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

February 02, 2026

After the Appendix Is Gone

A long-term pediatric cohort study raises new questions about gut immunity following appendectomy.

Conexiant

June 17, 2025

FMT as First-Line CDI Treatment?

New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant